Deborah Andrews's most recent trade in Staar Surgical Co. was a trade of 39,809 Restricted Stock Units done . Disclosure was reported to the exchange on March 13, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Staar Surgical Co. | Deborah Andrews | Interim Co-CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2026 | 39,809 | 39,809 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Deborah Andrews | Interim Co-CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 20,787 | 20,787 | - | - | Restricted Stock Units | |
| Staar Surgical Co. | Deborah Andrews | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 41,867 | 41,867 | - | - | Restricted Stock Units |